Krka plans 5% annual growth in sales in new 5-year strategy
Novo mesto, 22 March - Krka, the Novo Mesto-based pharmaceutical company, plans to record at least 5% annual growth in volume sales and sales revenue according to a new strategy until 2022 that Krka chairman Jože Colarič presented on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 1.318 characters (without spaces) or 245 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.